SNDX: Syndax Pharmaceuticals, Inc. Stock

by  •  • Comments Off on SNDX: Syndax Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,115.74
Enterprise Value ($M) 1,305.33
Book Value ($M) 288.12
Book Value / Share 3.35
Price / Book 3.87
NCAV ($M) 166.37
NCAV / Share 1.93
Price / NCAV 6.71

Profitability (mra)
Return on Invested Capital (ROIC) -0.50
Return on Assets (ROA) -0.59
Return on Equity (ROE) -0.65

Liquidity (mrq)
Quick Ratio 5.82
Current Ratio 5.82

Balance Sheet (mrq) ($M)
Current Assets 603.06
Assets 724.82
Liabilities 436.69
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 23.68
Operating Income -339.67
Net Income -318.76
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -274.90
Cash from Investing -219.78
Cash from Financing 353.37

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-07 13G/A Wellington Management Group Llp 0.00 -99.28
02-14 13G/A Kynam Capital Management, LP 9.98 50.53
02-12 13G Goldman Sachs Group Inc 7.00
02-05 13G Morgan Stanley 6.30
01-22 13G Point72 Asset Management, L.P. 5.00 50.92
12-06 13G/A BlackRock, Inc. 10.30 6.66
10-18 13G/A State Street Corp 4.40 -24.83

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-03 10-K 6884,826,632 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-03 175,717 911,172 19.28
2025-04-02 213,879 1,059,855 20.18
2025-04-01 523,070 2,287,402 22.87
2025-03-31 536,399 1,836,240 29.21

(click for more detail)

Similar Companies
SDGR – Schrödinger, Inc. SLDB – Solid Biosciences Inc.
SLRN – Acelyrin, Inc. SPRO – Spero Therapeutics, Inc.
SRPT – Sarepta Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io